Breaks Categories: News

WednesdayMar 23, 2022 11:16 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) New Brand Partners with Greenyard to Expand into Europe

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced that its recently acquired JustCBD brand is planning to open four brick-and-mortar locations in 2022 in the Czech Republic and Germany, with an additional 50 store openings planned in 2023. The company is partnering with German-based Greenyard to manage the new retail locations, which are under construction with planned openings in Q2 2022. Flora Growth anticipates additional growth throughout Europe moving forward. According to the announcement, the new stores will offer JustCBD’s complete product line, including gummies, tinctures, vape cartridges, creams, pet…

Continue Reading

ThursdayMar 17, 2022 11:43 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces New Board Appointments

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has made two significant changes to its board. The company named FLGC CEO Luis Merchan as board chair and announced that former Amazon executive Tim Leslie, who is currently serving as chair of Flora Growth’s advisory board, will join the company’s board of directors and audit committee. The company noted that the changes to the board indicate FLGC’s move toward becoming a U.S.-based issuer; the new appointments also support the company’s growth into new international markets. Merchan is replacing Bernie Wilson as board chair;…

Continue Reading

TuesdayMar 15, 2022 3:41 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Commencement of DehydraTECH-CBD Epilepsy Research Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that the first phase of its epilepsy research program EPIL-A21-1 is beginning this week. According to the update, the DehydraTECH(TM)-CBD test articles needed to commence dosing have already been manufactured and delivered to the third-party laboratory engaged to complete this research program. EPIL-A21-1 will assess the seizure inhibiting activity of DehydraTECH-CBD compared to the world's only FDA-approved CBD-based seizure medication, Epidiolex(R). Lexaria hopes to demonstrate superior performance based on DehydraTECH’s known advanced drug delivery capabilities. Lexaria's seizure program expects to leverage the significant gains in systemic…

Continue Reading

TuesdayMar 15, 2022 12:20 pm

CannabisNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Announces Receipt of 2022 Export Quota for High-THC Cannabis

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has received its annual export quote from the Colombian Ministry of Health and Social Protection. The company announced that the quota is for a total of 43,600 kg of high-THC cannabis, an updated quota that allows adequate export of medical cannabis products to meet Flora’s existing and future supply agreements in both bulk dry flower and derivatives. That allotment means Flora can produce and export both high-THC dry flower and cannabis derivative products and start to fulfill its previously announced agreements, including the agreement…

Continue Reading

TuesdayMar 15, 2022 10:54 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Registration in New Zealand for Proprietary IoT System

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a medical device certification in New Zealand for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). This comes in coordination with Medical Kiwi Ltd. as local sponsor for the New Zealand certification. Medical Kiwi is a New Zealand-based leader in R&D, manufacturing, cultivation and distribution of medical cannabis and medical devices. “We are pleased to continue gaining traction with medical device registration around the world and are excited to…

Continue Reading

MondayMar 14, 2022 3:19 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters Agreement to Bring Mind Naturals to Hong Kong and Key Global Markets

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into a distribution agreement with Israel-based DNO Group to distribute the Mind Naturals brand in the Hong Kong region. A leading distributor of global independent brands, DNO Group has over 50,000 points of sale throughout Asia in addition to its broader global reach. Under the agreement, Flora will work with DNO to identify growth opportunities and, using an omnichannel approach including brick-and-mortar retail, e-commerce and wholesale, bring the Mind Naturals brand to market in new territories. The initial focus will be…

Continue Reading

TuesdayMar 08, 2022 3:05 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Award for Oral Nicotine Compound Patent

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has been granted an Australian patent titled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof.” The patent expands Lexaria’s world patent portfolio to 24. According to the announcement, the patent expands the company’s international intellectual property rights to apply its proprietary DehydraTECH(TM) enhancement technology to most oral forms of nicotine delivery, which would include pills, tablets, lozenges, capsules, pouches, gums and sprays. In addition to covering different forms of delivery, the patent also includes an array of nicotine forms, such as free base nicotine, nicotine salts, polymer resins of nicotine…

Continue Reading

TuesdayMar 08, 2022 1:31 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at 34th Annual Roth Conference

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced that its president and CEO Eric A. Adams will be presenting at the 34th Annual Roth Conference being held March 13-15, 2022. Adams will host a fireside chat with Scoth Henry, managing director and head of pharmaceuticals research at Roth Capital Partners, on Tuesday, March 15. In addition to the live fireside chat, InMed’s virtual Roth Conference presentation is now available on-demand by visiting https://cnw.fm/ardpa. A webcast will be made available to investors following the event in the investor relations section of…

Continue Reading

TuesdayMar 08, 2022 12:21 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Approval from Health Canada Recognizing RYAH Smart Medical Inhaler System as Medical Device

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a Health Canada Medical Device License (“MDL”) for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). According to the update, Health Canada License number 107475 allows RYAH to market its Smart Medical Inhaler System to medical patients in Canada and potentially represents a significant boost to RYAH’s growth strategy. “The approval from Health Canada recognizing the RYAH Smart Inhaler System as a medical device is a major step towards…

Continue Reading

FridayMar 04, 2022 11:06 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes 1st US Import of CBD Products from Colombia

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it has completed its first import of CBD-containing food and beverage products into the United States from Colombia under its Mambe brand. The move comes after Colombian President Ivan Duque signed Resolution 227 last week, providing the necessary framework for the use, distribution and export of cannabis, dried flower and other non-psychoactive derivatives. “We are thrilled to be the first Colombian cannabis operator to capitalize on the law change President Duque signed into effect,” said Flora Growth CEO Luis Merchan. “We are…

Continue Reading